Back
Accenture PLC Vs. Keros Therapeutics Industry Stock Comparison
Sell
42
ACN
Accenture PLC
Last Price:
$282.50
Seasonality Move:
1.82%
Sell
18
KROS
Keros Therapeutics
Last Price:
$13.73
Seasonality Move:
16.92%
Sell
42
Accenture PLC (ACN)
is a Sell
Is Accenture PLC a Buy, Sell or Hold?
-
The current Accenture PLC [ACN] share price is $282.44. The Score for ACN is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
ACN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
18
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
-
The current Keros Therapeutics [KROS] share price is $13.75. The Score for KROS is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
-
KROS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
ACN Stock Price Chart
What is Accenture PLC's stock price today?
-
The Accenture PLC share price today is $282.44Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACN is experiencing slight buying pressure.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $13.75The current trend is moderately bullish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.
ACN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -7.31 | Sell |
Relative Strength Index (14 RSI): | 37.27 | Sell |
Chaikin Money Flow: | 555705 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (284.77 - 308.03) | Sell |
Bollinger Bands (100): | (289.52 - 328.46) | Sell |
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.95 | Buy |
Relative Strength Index (14 RSI): | 45.93 | Sell |
Chaikin Money Flow: | -348346 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.39 - 14.21) | Sell |
Bollinger Bands (100): | (11.5 - 14.52) | Buy |
ACN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 283.46 | Sell |
20-day SMA: | 292.37 | Sell |
50-day SMA: | 306.43 | Sell |
200-day SMA: | 336.07 | Sell |
8-day EMA: | 284.6 | Sell |
20-day EMA: | 292.25 | Sell |
50-day EMA: | 301.53 | Sell |
200-day EMA: | 322.55 | Sell |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.33 | Sell |
20-day SMA: | 13.86 | Sell |
50-day SMA: | 13.99 | Sell |
200-day SMA: | 25.5 | Sell |
8-day EMA: | 12.75 | Buy |
20-day EMA: | 8.47 | Buy |
50-day EMA: | 4.32 | Buy |
200-day EMA: | 1.23 | Buy |
Accenture PLC Earnings Growth & ACN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.29 per share, an increase next quarter of $0.03 per share, an increase this year of $0.97 per share, and an increase next year of $0.96 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.03 per share, an increase this year of $4.50 per share, and a decrease next year of $4.46 per share.
Accenture PLC Technical Analysis
Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Keros Therapeutics Technical Analysis
Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |